ECLAT Completes Management Buyout from Gulf Capital, Opening a New Chapter of Growth

The healthcare technology and revenue cycle management (RCM) industry continues to experience significant transformation as providers and payers increasingly adopt AI-powered solutions to improve operational efficiency, compliance, and financial performance. As healthcare organizations face mounting pressure to optimize revenue cycles while maintaining quality care, technology-driven service providers are playing a critical role in modernizing healthcare operations. In this evolving landscape, ECLAT management buyout marks a significant milestone for one of the industry's rapidly growing healthcare technology companies. ECLAT Health Solutions has successfully completed a management buyout (MBO) from Gulf Capital, returning full ownership of the company to its founders and leadership team after a highly successful five-year partnership.

The transaction signals the beginning of a new phase for ECLAT as it continues to expand its revenue cycle management, risk adjustment, and healthcare technology offerings while pursuing long-term growth opportunities in the healthcare sector.

ECLAT Returns to Founder and Management Ownership

ECLAT Health Solutions announced the completion of its management buyout from Gulf Capital, one of the leading private equity firms investing across the GCC and Asia. The transaction returns full ownership of the company to founders Karthik Polsani and Sneha Polsani, along with the broader management team. Financial details of the transaction were not disclosed.

The buyout concludes a five-year partnership that helped transform ECLAT into a diversified healthcare services platform with expanded technology capabilities, broader service offerings, and a significantly larger global footprint.

Industry analysts view management buyouts as strong indicators of leadership confidence, particularly when founders and executives choose to take greater ownership in future growth strategies.

Five Years of Remarkable Growth

During its partnership with Gulf Capital, ECLAT achieved substantial operational and financial growth. The company expanded from a relatively focused revenue cycle management provider into a technology-enabled healthcare services organization serving providers and payers across the United States.

Key achievements during the partnership include:

Tenfold growth in revenue
Tenfold growth in EBITDA
Approximately 75% EBITDA compound annual growth rate
Workforce expansion from 450 employees to over 4,000
Geographic expansion across the United States, India, and the Philippines
Diversification into payer-focused risk adjustment services and healthcare technology solutions

These milestones highlight the effectiveness of the company’s growth strategy and its ability to scale operations while maintaining service quality.

Expansion Beyond Traditional Revenue Cycle Management

Historically known for revenue cycle management services, ECLAT broadened its capabilities significantly under Gulf Capital’s ownership. The company expanded into adjacent healthcare segments to create a more comprehensive service platform.

The company now provides:

Revenue cycle management services
Risk adjustment solutions
Healthcare technology services
Clinical coding support
Payer analytics
Compliance-focused healthcare solutions

This diversification has helped ECLAT address evolving market demands while creating multiple growth opportunities within the healthcare ecosystem.

AI-Powered Innovation Drives Growth

A major contributor to ECLAT’s success has been the development of its proprietary AI and analytics platform, evaire. The platform leverages advanced analytics and agentic AI technologies to support healthcare providers and payers in managing complex operational workflows.

The evaire platform supports:

Chart retrieval and review
Risk adjustment coding
Confidence scoring
Payer analytics
Clinical documentation analysis
Revenue optimization initiatives

Industry experts believe AI-powered healthcare platforms will continue driving efficiency improvements across revenue cycle management and payer operations.

Growing Importance of Revenue Cycle Management

Revenue cycle management remains one of the most important operational functions within healthcare organizations. As reimbursement models become more complex, healthcare providers increasingly rely on specialized partners to improve financial performance and administrative efficiency.

Modern RCM solutions help organizations:

Reduce claim denials
Improve reimbursement accuracy
Strengthen compliance
Increase operational efficiency
Enhance revenue visibility
Improve patient financial experiences

Industry analysts expect demand for technology-enabled RCM solutions to continue rising as healthcare organizations focus on cost management and operational excellence.

Risk Adjustment Services Gain Momentum

Risk adjustment has become a critical area of focus for healthcare payers and value-based care organizations. Accurate risk adjustment coding directly impacts reimbursement levels and financial performance.

ECLAT’s expansion into this area enables the company to help clients:

Improve coding accuracy
Strengthen documentation quality
Optimize reimbursement outcomes
Reduce compliance risks
Enhance population health management

Industry experts note that growing adoption of value-based care models will likely increase demand for specialized risk adjustment services.

Gulf Capital’s Role in ECLAT’s Transformation

Gulf Capital played a significant role in helping ECLAT scale its operations and expand its market presence. The private equity firm worked closely with the leadership team to strengthen organizational capabilities, improve operational processes, and support strategic growth initiatives.

During the partnership, Gulf Capital helped:

Expand service offerings
Professionalize operations
Strengthen leadership capabilities
Support acquisitions and expansion
Accelerate technology investments

The investment is widely regarded as one of the most successful exits within Gulf Capital’s portfolio.

Strategic Acquisitions Supported Growth

ECLAT’s growth strategy also included strategic acquisitions that enhanced its capabilities and market reach. Previous acquisitions helped strengthen its position within the revenue cycle management sector while expanding service coverage across the healthcare ecosystem.

Industry observers note that acquisitions remain an important growth strategy for healthcare technology providers seeking to expand capabilities and market share.

The company’s expanded service portfolio positions it well for future opportunities within the rapidly evolving healthcare technology market.

Leadership Focuses on Long-Term Growth

With ownership returning to founders and management, ECLAT is expected to focus on continued expansion and innovation. Leadership has expressed confidence in the company’s ability to build upon the momentum achieved during the Gulf Capital partnership.

Future priorities are expected to include:

Organic business growth
Technology innovation
Expansion of payer partnerships
Strengthening provider relationships
Strategic acquisition opportunities
Continued AI investment

Industry analysts believe founder-led organizations often benefit from long-term strategic alignment and entrepreneurial agility.

Healthcare Technology Market Continues Expanding

The healthcare technology market continues to experience strong growth as providers and payers seek solutions that improve efficiency, reduce costs, and enhance patient outcomes.

Major investment areas include:

Artificial intelligence
Revenue cycle management
Clinical analytics
Risk adjustment technology
Healthcare automation
Data intelligence platforms

Industry experts predict sustained growth as healthcare organizations accelerate digital transformation initiatives.

Companies like ECLAT are well-positioned to capitalize on these trends through technology-enabled service offerings.

AI Becomes Central to Healthcare Operations

Artificial intelligence is increasingly influencing healthcare administration and financial management. AI-driven solutions help organizations process large volumes of data while improving accuracy and operational efficiency.

Healthcare AI applications include:

Clinical documentation analysis
Revenue optimization
Coding automation
Predictive analytics
Workflow automation
Compliance monitoring

Industry analysts expect AI adoption within healthcare operations to continue accelerating over the coming years.

ECLAT’s investment in evaire demonstrates the company’s commitment to remaining at the forefront of healthcare technology innovation.

Opportunities in Global Healthcare Services

ECLAT’s global workforce and operational footprint provide significant opportunities for continued expansion. The company now operates across multiple countries and serves a growing client base within the U.S. healthcare market.

Global healthcare service providers benefit from:

Access to specialized talent
Operational scalability
Cost efficiencies
Expanded service capabilities
Enhanced client support

Industry observers expect globalization to remain an important factor in healthcare service delivery models.

Future Outlook for ECLAT

The completion of the management buyout positions ECLAT for its next phase of growth as an independent, founder-led organization. With strong operational foundations, advanced technology capabilities, and a growing client base, the company appears well-positioned to pursue new opportunities within healthcare technology and revenue cycle management.

Key growth drivers may include:

Increased adoption of AI-powered healthcare solutions
Expansion of payer-focused services
Growth in value-based care initiatives
Continued demand for revenue optimization
Strategic partnerships and acquisitions

Industry experts believe organizations that combine healthcare expertise with advanced technology capabilities will continue gaining market share.

Conclusion

ECLAT Health Solutions’ successful management buyout from Gulf Capital marks a significant milestone in the company’s journey. After five years of transformative growth, expanded capabilities, and substantial financial success, the company has returned to full founder and management ownership while maintaining strong momentum for future expansion.

Supported by its AI-powered evaire platform, diversified service portfolio, and experienced leadership team, ECLAT is entering a new chapter focused on innovation, strategic growth, and delivering value to healthcare providers and payers. As healthcare organizations continue modernizing operations and embracing technology-driven solutions, ECLAT is positioned to play an increasingly important role in the future of healthcare revenue management and analytics.

Discover RevTech News for the latest updates on financial innovation and revenue-driven technology.